pitfalls. Proteomics Clinical Applications, 9, 406–422.
Timmerman, P. (2016). Biomarker assay validation: Are we having the right discussions?
Bioanalysis, 8, 2299–2303.
Valentin, M. A., Ma, S., Zhao
y
421 MAP Kinase, Monophosphorylated Tyrosine M3682 5594 MAPK1 M NP_002736.3,NP_620407.1 , y n/d y
422 MAP Kinase, Activated (Diphosphorylated ERK-1&2) M9692 5594 MAPK1 M NP_002736.3,NP_620407.1 , y y y
y
421 MAP Kinase, Monophosphorylated Tyrosine M3682 5594 MAPK1 M NP_002736.3,NP_620407.1 , y n/d y
422 MAP Kinase, Activated (Diphosphorylated ERK-1&2) M9692 5594 MAPK1 M NP_002736.3,NP_620407.1 , y y y
y
421 MAP Kinase, Monophosphorylated Tyrosine M3682 5594 MAPK1 M NP_002736.3,NP_620407.1 , y n/d y
422 MAP Kinase, Activated (Diphosphorylated ERK-1&2) M9692 5594 MAPK1 M NP_002736.3,NP_620407.1 , y y y
Phosphothreonine ERK-1&2) M7802 M y n/d y
421 MAP Kinase, Monophosphorylated Tyrosine M3682 M y n/d y
422 MAP Kinase, Activated (Diphosphorylated ERK-1&2) M9692 M y y y
423 MAP Kinase, Monophosphorylated Threonine